| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 6/6 |
Rewards
Risk Analysis
No risks detected for 500488 from our risk checks.
Abbott India Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹28,637.90 |
| 52 Week High | ₹29,628.15 |
| 52 Week Low | ₹21,907.45 |
| Beta | 0.033 |
| 11 Month Change | 3.62% |
| 3 Month Change | 10.72% |
| 1 Year Change | 19.04% |
| 33 Year Change | 50.05% |
| 5 Year Change | 236.48% |
| Change since IPO | 4,924.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| 500488 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 4.5% | 2.2% | -1.0% |
| 1Y | 19.0% | 46.7% | 43.6% |
Return vs Industry: 500488 underperformed the Indian Pharmaceuticals industry which returned 46.7% over the past year.
Return vs Market: 500488 underperformed the Indian Market which returned 43.6% over the past year.
Price Volatility
| 500488 volatility | |
|---|---|
| 500488 Average Weekly Movement | 3.3% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in IN Market | 9.7% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 500488 has not had significant price volatility in the past 3 months.
Volatility Over Time: 500488's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1910 | 3,814 | Swati Dalal | www.abbott.co.in |
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women’s health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products.
Abbott India Limited Fundamentals Summary
| 500488 fundamental statistics | |
|---|---|
| Market cap | ₹595.03b |
| Earnings (TTM) | ₹12.01b |
| Revenue (TTM) | ₹58.49b |
50.7x
P/E Ratio10.4x
P/S RatioIs 500488 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 500488 income statement (TTM) | |
|---|---|
| Revenue | ₹58.49b |
| Cost of Revenue | ₹32.33b |
| Gross Profit | ₹26.16b |
| Other Expenses | ₹14.15b |
| Earnings | ₹12.01b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 565.30 |
| Gross Margin | 44.73% |
| Net Profit Margin | 20.54% |
| Debt/Equity Ratio | 0% |
How did 500488 perform over the long term?
See historical performance and comparison